检验医学 ›› 2026, Vol. 41 ›› Issue (2): 169-176.DOI: 10.3969/j.issn.1673-8640.2026.02.011

• 论著 • 上一篇    下一篇

p53、p300、miR-944表达在非小细胞肺癌患者预后评估中的价值

盖慧荣1, 周师慧2, 李伟1, 李新3()   

  1. 1.康复大学青岛中心医院内二科山东 青岛 266042
    2.康复大学青岛中心医院医务部山东 青岛 266042
    3.康复大学青岛中心医院中西医结合科山东 青岛 266042
  • 收稿日期:2024-01-15 修回日期:2025-05-05 出版日期:2026-02-28 发布日期:2026-03-06
  • 通讯作者: 李 新,E-mail:lixin2025@163.com
  • 作者简介:盖慧荣,女,1981年生,硕士,主治医师,主要从事肿瘤诊治工作。

Roles of p53,p300 and miR-944 expressions in prognosis assessment of non-small cell lung cancer patients

GAI Huirong1, ZHOU Shihui2, LI Wei1, LI Xin3()   

  1. 1. Department 2 of Internal MedicineQingdao Central Hospital,University of Health and Rehabilitation SciencesQingdao 266042,Shandong, China
    2. Medical DepartmentQingdao Central Hospital,University of Health and Rehabilitation SciencesQingdao 266042,Shandong, China
    3. Department of Chinese and Western MedicineQingdao Central Hospital,University of Health and Rehabilitation SciencesQingdao 266042,Shandong, China
  • Received:2024-01-15 Revised:2025-05-05 Online:2026-02-28 Published:2026-03-06

摘要:

目的 探讨癌组织p53、p300蛋白和miR-944表达在非小细胞肺癌(NSCLC)患者预后评估中的价值。方法 选取2016年6月—2018年6月青岛市肿瘤医院NSCLC患者40例。收集所有患者的癌组织和癌旁组织(距肿瘤边缘>5 cm),检测p53、p300蛋白表达和miR-944相对表达量。另收集所有患者的临床资料和实验室检测数据。对所有患者随访5年,根据存活情况分为死亡组(10例)和存活组(30例)。采用Logistic回归分析评估NSCLC患者死亡的影响因素。采用受试者工作特征(ROC)曲线评价p53、p300、miR-944判断NSCLC患者死亡的效能。采用Kaplan-Meier生存曲线分析NSCLC患者的生存情况。结果 NSCLC患者癌组织p53、p300阳性率和miR-944相对表达量均高于癌旁组织(P<0.05)。不同TNM分期、分化程度和有无淋巴转移的NSCLC患者p53、p300阳性率和miR-944相对表达量差异均有统计学意义(P<0.05)。死亡组和存活组TNM分期、吸烟史、淋巴转移情况、分化程度、白蛋白(Alb)和p53、p300阳性率,以及miR-944相对表达量差异均有统计学意义(P<0.05)。TNM分期Ⅲ+Ⅳ期、有吸烟史、有淋巴转移、Alb≤35 g·L-1、分化程度低、p53阳性、p300阳性、miR-944升高均是NSCLC患者死亡的危险因素(P<0.05)。p53、p300、miR-944单项检测和联合检测判断NSCLC患者死亡的曲线下面积(AUC)分别为0.641、0.686、0.677、0.878。p53阴性组、p300阴性组和miR-944低表达组总生存率分别高于p53阳性组、p300阳性组、miR-944高表达组(Log-rank χ2值分别为6.372、7.127、5.429,P<0.05)。结论 NSCLC患者癌组织中p53、p300蛋白和miR-944均呈高表达,且与临床病理特征和预后密切相关,或可作为NSCLC患者预后评估的指标。

关键词: p53蛋白, p300蛋白, miR-944, 非小细胞肺癌, 预后

Abstract:

Objective To investigate the roles of p53,p300 and miR-944 expressions in cancer tissues in the prognosis assessment of non-small cell lung cancer(NSCLC)patients. Methods Totally,40 NSCLC patients from Qingdao Cancer Hospital from June 2016 to June 2018 were enrolled. Cancer tissues and adjacent tissues(>5 cm away from tumor margin)were collected to determine the expressions of p53,p300 and the relative expression level of miR-944. The clinical data and laboratory determination results were collected. All the patients were followed up for 5 years and were classified into death group(10 cases)and survival group(30 cases)according to their survival status. Logistic regression analysis was used to evaluate the influencing factors of death in NSCLC patients. Receiver operating characteristic(ROC)curve was used to evaluate the efficacy of p53,p300 and miR-944 in predicting death in NSCLC patients. Kaplan-Meier survival curve was used to analyze the survival status of NSCLC patients. Results The positive rates of p53 and p300 and the relative expression level of miR-944 in cancer tissues were higher than those in adjacent tissues(P<0.05). There was statistical significance in the positive rates of p53 and p300 and the relative expression level of miR-944 among NSCLC patients with different TNM stages,differentiation degrees and lymphatic metastasis(P<0.05). There was statistical significance in TNM stage,smoking history,lymphatic metastasis,differentiation degree,albumin(Alb),the positive rates of p53 and p300 and the relative expression level of miR-944 between death group and survival group(P<0.05). TNM stage Ⅲ+Ⅳ,smoking history,lymphatic metastasis,Alb≤35 g·L-1,low differentiation degree,positive p53,positive p300 and elevated miR-944 were all risk factors for death in NSCLC patients(P<0.05). The areas under curves(AUC)of single and combined determinations of p53,p300 and miR-944 in predicting death in NSCLC patients were 0.641,0.686,0.677 and 0.878,respectively. The total survival rates of p53 negative group,p300 negative group and miR-944 low expression group were all higher than those of p53 positive group,p300 positive group and miR-944 high expression group(Log-rank χ2 values were 6.372,7.127,5.429,respectively,P<0.05). Conclusions The p53,p300 and miR-944 are highly expressed in cancer tissues of NSCLC patients and are related to the clinical pathological characteristics and prognosis. They may serve as indicators for prognosis assessment in NSCLC patients.

Key words: P53 protein, P300 protein, MiR-944, Non-small cell lung cancer, Prognosis

中图分类号: